FOPE submitted key recommendations to NITI Aayog during the FABA Roundtable, focusing on empowering MSMEs in the pharma and biotech sectors. Highlights include:
Ease of Doing Business: Tax benefits for R&D, single-window clearance.
API Self-Reliance: PLI support and common facility centers.
Innovation: Stronger public-private partnerships and biotech incubators.
Funding: Venture capital, soft loans, and credit guarantees.
Exports: Incentives for global certifications and promoting "Brand India Pharma."
Skilling: Specialized training and leadership development.
Transition Support: Assistance for SMEs unable to meet new norms.
These suggestions aim to build a globally competitive, innovation-driven MSME ecosystem.